Patients who had had PCI with an SGLT2 inhibitor had a smaller increase in creatinine levels and, as a result, a reduced incidence of CI-AKI (3.8% vs 17.3%, p = 0.05) (117) (118). Here, SLC5A2 is linked to acute kidney injury.